» Articles » PMID: 20945317

The Role of Epigenetic Transcription Repression and DNA Methyltransferases in Cancer

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 2010 Oct 15
PMID 20945317
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Epigenetic alterations such as DNA methylation have been implicated in the development and progression of various cancers. DNA methylation consists of the reversible addition of a methyl group to the carbon 5 position of cytosine in CpG dinucleotides and is considered essential for normal embryonic development. However, global genomic hypomethylation and aberrant hypermethylation of regulatory regions of tumor suppressor genes have been associated with chromosomal instability and transcription repression, respectively, providing neoplastic cells with a selective advantage. DNA methyltransferases are the enzymes responsible for the addition of methyl groups to CpG dinucleotides, which, together with histone modifiers, initiate the events necessary for transcription repression to occur. It has been demonstrated that increased expression of DNA methyltransferases may contribute to tumor progression through methylation-mediated gene inactivation in various human cancers. Given their importance, this article reviews the main epigenetic mechanisms for regulating transcription and its implications in cancer development.

Citing Articles

Targeting the epigenome with advanced delivery strategies for epigenetic modulators.

Guha S, Jagadeesan Y, Pandey M, Mittal A, Chitkara D Bioeng Transl Med. 2025; 10(1):e10710.

PMID: 39801754 PMC: 11711227. DOI: 10.1002/btm2.10710.


Prediction of the binding mechanism of a selective DNA methyltransferase 3A inhibitor by molecular simulation.

Kudo G, Hirao T, Harada R, Hirokawa T, Shigeta Y, Yoshino R Sci Rep. 2024; 14(1):13508.

PMID: 38866895 PMC: 11169543. DOI: 10.1038/s41598-024-64236-9.


Possible Strategies to Reduce the Tumorigenic Risk of Reprogrammed Normal and Cancer Cells.

Lin Y, Ku C, Wuputra K, Liu C, Wu D, Satou M Int J Mol Sci. 2024; 25(10).

PMID: 38791215 PMC: 11120835. DOI: 10.3390/ijms25105177.


Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies.

Cao X, Jin X, Zhang X, Utsav P, Zhang Y, Guo R Curr Treat Options Oncol. 2023; 24(3):184-211.

PMID: 36701037 PMC: 9992085. DOI: 10.1007/s11864-023-01049-4.


A pyroptosis-related gene signature for prognosis and immune microenvironment of pancreatic cancer.

Tao S, Tian L, Wang X, Shou Y Front Genet. 2022; 13:817919.

PMID: 36118860 PMC: 9476319. DOI: 10.3389/fgene.2022.817919.